Skip to main content

Table 5 Skeletal and dental treatment effects in the facemask group

From: Early Class III treatment with Hybrid-Hyrax -Facemask in comparison to Hybrid-Hyrax-Mentoplate – skeletal and dental outcomes

Variables

Facemask T0

Facemask T1

p values

CI 95%

 

SNA°

79.41 ± 2.86

81.66 ± 2.92

0.000*

1.60

2.90

SNB°

80.51 ± 3.26

79.02 ± 3.27

0.000*

− 2.06

− 0.91

ANB°

− 1.10 ± 1.98

2.65 ± 2.34

0.000*

3.00

4.49

WITS mm

− 5.39 ± 1.47

− 0.57 ± 1.51

0.000*

4.02

5.52

ATV mm

59.99 ± 2.99

62.42 ± 3.47

0.000*

1.71

3.13

BTV mm

59.32 ± 4.78

57.52 ± 5.05

0.002*

− 2.81

− 0.74

ABTV mm

0.67 ± 3.16

4.90 ± 3.60

0.000*

3.30

5.14

ML-NL°

26.06 ± 5.44

27.95 ± 6.12

0.000*

1.03

2.74

ML-NSL°

32.65 ± 6.27

33.79 ± 6.11

0.149

0.37

1.90

NSL-NL°

6.58 ± 2.93

5.84 ± 3.96

0.148 (W)

− 0.27

1.76

AR-GO-ME°

126.92 ± 7.05

127.33 ± 6.92

0.001*

0.19

0.61

MOK-A mm

26.37 ± 2.21

26.30 ± 2.19

0.246

− 0.05

0.19

U1-PP°

108.19 ± 7.85

107.04 ± 6.92

0.473

− 2.16

4.47

L1-ML°

86.87 ± 6.27

83.04 ± 4.26

0.028* (W)

− 6.99

− 0.67

  1. W Wilcoxon
  2. *significant at p < 0.05